NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cephalon, Inc. 

Corporate Headquarters
41 Moores Road
Frazer  Pennsylvania  19355  U.S.A.
Phone: 610-344-0200 Fax: 610-344-0981


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Bristol-Myers Squibb Pharmaceutical Research Institute  Stadol NS® for pain management and Serzone® (nefazodone hydrochloride) for depression

LEO Pharma China 

TAP Holdings 





 Company News
Cephalon, Inc. (CEPH), Barr Pharmaceuticals, Inc. (BRL) Settle Patent Infringement Suit 11/13/2009 6:54:55 AM    More...
Cephalon, Inc. (CEPH) to Webcast R&D Day 11/5/2009 8:37:52 AM    More...
Cephalon, Inc. (CEPH) Signs Option Agreement to Acquire BioAssets Development Corporation; Cephalon Will Pay $30 Million Upfront 10/26/2009 6:49:25 AM    More...
Cephalon, Inc. (CEPH) Notified of Generic Filing for Armodafinil Tablets 10/22/2009 9:00:14 AM    More...
Cephalon, Inc. (CEPH) Third Quarter 2009 Earnings Conference Call to be held Tuesday, October 27, 2009 at 5:00 p.m. EDT 9/30/2009 10:36:46 AM    More...
ImmuPharma plc (IMM.L) Swings to H1 Profit After Cephalon, Inc. (CEPH) Deal 9/29/2009 7:13:49 AM    More...
Cephalon, Inc. (CEPH) Sleep Drug Wins Fast Review for Jet Lag 9/24/2009 7:23:17 AM    More...
CytRx Corporation (CYTR) and Cephalon, Inc. (CEPH) Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia 9/14/2009 9:34:13 AM    More...
XOMA (US) LLC (XOMA) (JOBS), Cephalon, Inc. (CEPH) Unit in $6 Million Antibody Discovery Deal 9/9/2009 6:50:23 AM    More...
Cephalon, Inc. (CEPH) Completes Acquisition of Arana Therapeutics, Acquisition Diversifies Cephalon Technology Portfolio and Forms Foundation for Biologics Business 8/11/2009 8:56:17 AM    More...
12345678910...